Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 639Head and Neck Neoplasms 612Carcinoma, Non-Small-Cell Lung 203Thyroid Neoplasms 199Melanoma 145Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 130Colorectal Neoplasms 130Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 113Lung Neoplasms 107Ovarian Neoplasms 105Uterine Cervical Neoplasms 100Neoplasm Metastasis 93Carcinoma, Squamous Cell 87Stomach Neoplasms 84Carcinoma, Renal Cell 83Triple Negative Breast Neoplasms 78Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 68Endometrial Neoplasms 66Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 46Carcinoma, Hepatocellular 45

Interventions

Radiotherapy, Intensity-Modulated 1Immune Checkpoint Inhibitors 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nasopharyngeal Cancinoma (NPC) × Head & Neck × 1 year × Clear all
NCT07013461 2026-05-04

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

The University of Hong Kong-Shenzhen Hospital

Recruiting
5,000 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting
516 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡